v3 Template
I

Invirsa Inc.

Biotechnology/Pharmaceuticals ~120 employees
Founded
--
Employees (Est.)
~120
8 leaders known
Total Funding
$7.7M
Funding Rounds
1
Last Funding
2023-06-14

About Invirsa Inc.

Invirsa is a company focused on developing treatments that enhance the body's response to DNA damage, aiming to improve cell stability and recovery. Their mission centers on innovative drug development for significant health challenges, particularly in ocular conditions.

Products & Services

INV-102:A lead compound that augments the body's response to DNA damage, improving cell stability and aiding in DNA repair. It is being developed for ocular injuries from sulphur mustard gas and acute infectious keratoconjunctivitis.

Specialties

DNA damage response Ocular injury treatment Infectious keratoconjunctivitis treatment Drug development for big market pharmaceuticals

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 7700000
MR: -
FA: 7.7 million
FAN: 7700000 		D: 2023-06-14
FD: 2023-06-14 		4 investors
Series B Latest
2023-06-14
$7.7M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Robert Shalwitz

Pediatric Endocrinologist

LinkedIn (Pro only)
R

Rachael Wingo

Financial Leader

LinkedIn (Pro only)
I

Isaiah Shalwitz

Biostatistician and Program Manager in Pharmaceutical Development

LinkedIn (Pro only)
C

Cindy Flinn

Program Leader

K

Kenneth Beckman

M.D.

E

Eric Donnenfeld

M.D.

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Invirsa Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals
Company Size
~120 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro